Brief: Allarity Therapeutics Announces Final Settlement With The U.S. Securities And Exchange Commission
13/03/2025 14:39
March 13 (Reuters) - Allarity Therapeutics Inc ALLR.O: ALLARITY THERAPEUTICS ANNOUNCES FINAL SETTLEMENT WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION ALLARITY THERAPEUTICS: CONSENTED, WITHOUT ADMITTING OR DENYING SEC'S FINDINGS, TO ENTRY OF ADMINISTRATIVE CEASE-AND-DESIST ORDER Source text: ID:nGNXbQpZD8 Further company coverage: ALLR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic